At the end of May, Huaren Pharmaceutical received three new utility model patent authorization certificates. They are “a new type of combined peritoneal distension liquid cover cover”, “protective cover construction and disinfection device”, and “the ability to close the bridge of the nose.” The acquisition of these three patents is a full affirmation of the company’s first-line researchers to continuously improve and improve the process technology, and it is also a positive return for the company to actively seek new drugs to support scientific research and seek technological innovation. The three patents enable the company to achieve greater results on the basis of existing intellectual property rights, further enhance the company’s product strength construction level, enhance the core competitiveness, and further consolidate the foundation of the company’s strength.